規制動向

FDA、EMA、TGA および世界の規制動向

#CILOSTAZOL ×

2026年9月3日•1分で読めます

FDA Approves Apotex CILOSTAZOL (ANDA077030)

FDA has approved Apotex's oral cilostazol tablets (50 mg and 100 mg) under ANDA 077030, adding a generic phosphodiesterase‑3 inhibitor to the market.

2026年8月30日•1分で読めます

FDA Approves CILOSTAZOL Tablets (ANDA077831)

FDA has approved Chartwell Rx's ANDA077831 for oral CILOSTAZOL tablets in 50 mg and 100 mg strengths, with labeling updates approved in 2016.